biotechnology – HedgeChatter

Janet Yellen comments on biotech valuations in 2014 – Business …

Janet Yellen is facing Congress on Wednesday for her semi-annual testimony.And one year ago today, Yellen’s monetary policy report warned about stock market valuations, particularly in social media and biotech stocks. It was an awful call. Yellen’s testimony last year said:”Some broad equity price indexes have increased to all-time highs in nominal terms since the end of 2013. However, valuation measures for the overall market in […]

July 15, 2015 ByAkin Oyedele biotechnology, congress, historical, hit-mute, ishares, javascript, king, since-yellen, social, video, wednesday, year Comments Off read more

Biotech stock bubble set for massive implosion: Stocks rose 88 …

(NaturalNews) If you’re trying to understand today’s stock market and are having some degree of difficulty, you’re not alone.The markets are confusing enough sometimes for experts, so they can be particularly baffling for laypersons. Still, a few economic basics ought to be pretty simple to understand, right?Wrong – apparently.About a year ago, as documented by the Zero Hedge website, Federal […]

July 8, 2015 ByBy J. D. Heyes biotechnology, budget, court, facebook, federal, government, island, janet, museum, naturalnews, social-security Comments Off read more

5 Biotech Stocks On Deck With The FDA – Benzinga

Some traders like to gamble on big news events that could have a dramatic effect on a particular stock. For example, the release of a company’s earnings report could cause an underlying stock to jump to new highs or drop to significant lows. While this may not interest all investors, it does prove to be a point of intrigue for […]

June 30, 2015 ByChristian Tharp CMT benzinga, biotechnology, crisis, eteplirsen, fda, greek, monday, nda, obeticholic, public Comments Off read more

Is This The Chart That Scared Yellen Capital Out Of Biotechs?

Nope, no bubble here at all. Biotechs driven by fun-durr-mentals like everything else…*)As Bloomberg reports, perhaps there is a limit it this insanity. Demand for options tied to declines in an exchange-traded fund tracking the companies rose to the highest level in three years relative to bullish ones, according to data compiled by Bloomberg. The Nasdaq Biotechnology Index has risen […]

June 25, 2015 ByGhovexx biotechnology, bloomberg, capital, chair-janet, federal-reserve, fogertey, market, warren Comments Off read more

Finding The Next Blockbuster Biotech Stock – ETF Daily News

Kyle Anderson: Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.That’s why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.Have you ever wondered how billionaires continue to get RICHER, while the rest of […]

June 23, 2015 ByDavid Bettencourt biotech-stock, biotechnology, black, company, health, investing, news, process, protein, therapeutics, world Comments Off read more

Rising Risk Aversion

While Thursday’s weak CPI report gave hope that inflation might stay too low for the Fed to realistically raise rates, much of the week’s equity rally had more to do with four weeks of steadily receding momentum than with the hope that rate hikes might be postponed into 2016 – even the more dovish Fed couldn’t stand in the way […]

June 22, 2015 ByETF Global www.etfg.com biotechnology, capital, chinese, europe, exchange, greece, hedged, ishares, msci, nasdaq Comments Off read more

Stock Market News for June 19, 2015 – Zacks Investment Research

Benchmarks gained around 1% on Thursday after the Federal Reserve hinted that it will move slowly on raising interest rates. A majority of Fed officials had said on Wednesday that the economy is ready for a rate hike this year. Only 2 out of the 17 officials believe the central bank should not raise rates before next year. Meanwhile, consumer […]

June 19, 2015 ByZacks Equity Research biotechnology, conference, consumer, federal, federal-reserve, gene, industrial, labor, nyse, philadelphia, report Comments Off read more

Stock Market News for May 15, 2015 – Zacks Investment Research

Benchmarks gained over 1% yesterday on weaker dollar and drop in bond yields. Thursday’s gains were broad based with the S&P 500 closing at an all-time record high and 9 out of 10 sectors of the index ending in positive territory. Economic data was mixed, giving no clear indication to investors on the timing of first rate hike.For a look […]

May 15, 2015 ByZacks Equity Research analyst, biotechnology, economic, federal, gene, king, labor, president, producer, standard, technology, thursday Comments Off read more

US stock indexes move higher in afternoon trading – seattlepi.com

Major stock indexes were heading for a higher close late Thursday afternoon, with the Standard & Poor’s 500 index on track for another all-time high. The market got a lift from new data indicating applications for unemployment aid fell last week. Technology and consumer staples stocks were among the biggest gainers.KEEPING SCORE: The Dow Jones industrial average rose 185 points, […]

May 14, 2015 ByBy ALEX VEIGA AP Business Writer biotechnology, energy, europe, germany, international, labor, london, officer, technology Comments Off read more

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs …

Mergers & acquisitions once again took center stage in the biotech sector with Alexion (ALXN – Analyst Report) announcing its intention to acquire Synageva (GEVA – Snapshot Report). Meanwhile, there were some important updates on the regulatory and pipeline front from companies like Vertex (VRTX – Analyst Report) and Orexigen (OREX – Analyst Report).Recap of the Week’s Most Important Stories1. […]

May 13, 2015 ByArpita Dutt ALXN, analyst-report, biotechnology, company, contrave, executive, king, major, takeda Comments Off read more